In early February, Concentrol had the honor of participating in the inaugural meeting of the Business Council of the Josep Trueta Biomedical Research Institute of Girona (IDIBGI). This advisory body, composed of prominent representatives from the business and healthcare sectors, aims primarily to facilitate the transfer of scientific knowledge and technology to the productive sector.
The collaboration between Concentrol and IDIBGI is longstanding. For years, Concentrol has been an active collaborator of IDIBGI and has contributed to fundraising efforts for biomedical research, demonstrating its commitment to scientific advancement and social well-being.
IDIBGI is a renowned institute focused on translational research to improve health and patient care. With 23 research groups across five scientific areas and more than 400 healthcare professionals and basic researchers, IDIBGI is a benchmark in biomedical research in the Girona region. Its cutting-edge projects address the mechanisms of diseases in areas such as Oncohematology, Metabolism and Inflammation, Cardiovascular and Respiratory Diseases, Neuroscience, Medical Imaging, and Mental Health, among others.
Concentrol reafirma su compromiso de seguir trabajando estrechamente con el IDIBGI y otras instituciones para impulsar la investigación biomédica translacional y contribuir al futuro de la salud y el bienestar de las personas.
At Concentrol, our goal is to innovate with chemistry to make a positive impact on society and the planet. Participation in the Business Council of IDIBGI represents a significant step in that direction. This close collaboration between biomedical research and the business sector opens new opportunities for innovation and progress in the health and well-being of individuals.
Concentrol reaffirms its commitment to continue working closely with IDIBGI and other institutions to promote translational biomedical research and contribute to the future of health and well-being for people.
